Real-World Effectiveness and Safety of Extrafine Triple Therapy in COPD Patients with Comorbid and Cardiovascular Conditions. (PubMed, Int J Chron Obstruct Pulmon Dis) - Jul 14, 2026 - "This analysis provides real-world evidence supporting extrafine BDP/FF/GB SITT as an effective and safe option for COPD patients with comorbidities, including CV history or risk. These findings help address an evidence gap in vulnerable populations and support timely initiation of SITT in high-risk patients in clinical practice."
Journal • Real-world evidence • Cardiovascular • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases
|
|
Alessio Piraino; Daiana Stolz; Elena Nudo; Guy Brusselle; Laura Franzini; Luca Di Palma; Paola Rogliani; Petros Bakakos
|